 |
|
Medicinal Range |
|
|
Animal Health |
|
|
Personal Care |
|
|
|
|
|
|
|
|
To view the clinical papers, your system needs the free Adobe Acrobat Reader, version 4 or later.
Click here to download. |
|
|
 |
|
| Total no. of papers:4 -
Clinical Papers:4, Experimental
Papers:0 |
| (Research papers
based on Indications) |
| Highlighted journal
names are international publications |
| |
| In the prevention
and treatment of viral hepatitis |
|
- Evaluation
of efficacy and safety of Liv.52 DS tablets in acute viral hepatitis: A prospective,
double-blind, randomized, placebo-controlled, phase III clinical trial
Dr. Rajiv Baijal, M.D., D.N.B.1, Dr. Nikhil Patel,
M.D.,2 and Dr. S. A. Kolhapure, M.D.3* 1Gastroenterologist,
2Research Associates, Department of Gastroenterology, Jagjivanram Western Railway
Hospital, Mumbai Central, Mumbai, India, 3Senior Medical Advisor, R&D Center,
The Himalaya Drug Company, Bangalore, India, Medicine Update 2004; 12(5), 41-53.
|
 |
| |
|
| As an adjuvant with hepatotoxic drugs like anti-tubercular drugs, statins, chemotherapeutic agents, and antiretrovirals
|
|
- Liv.52 DS tablets: Evaluation of Liv.52 DS tablet as a hepatoprotective agent in prophylaxis with statin therapy
Das, JKL, Associate professor, Department of Medicine, Patna Medical College, Patna, India, Prasad, S.R., Mitra S.K., R&D Center, The Himalaya Drug Company, Bangalore, India. Medicine Update 2007; 15(7): 31-36
|
|
| |
|
| In the prevention
and treatment of alcoholic liver disease |
|
- Study of the efficacy and safety of Liv.52 DS tablets in alcoholic hepatitis: Clinical, biochemical and ultrasonographic evaluation.
Arun Kumar Mahto, Professor and HOD, Chief Investigator, Sailal, M., Junior Resident, Assistant Investigator and Monitor, Department of Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India. Indian Medical Journal 2009; 103(5): 150-158.
- Liv.52 DS tablets: Evaluation of efficacy and safety in alcoholic liver cirrhosis
Subhash Agal, Dept. of Gastroenterology, Jagagivanram Western Railway Hospital, Mumbai, and Dr. Prasad, S.R., Mitra S.K., R&D Center, The Himalaya Drug Company, Bangalore, India. Medicine Update 2007; 15(6): 25-32
|
|
|
|
| |
|
|
